Press Releases
Chaffetz, Cummings Request Further Details on EpiPen ProfitsLetter requests detailed financial information on sales, profits, costs, etc. |
House Republicans Issued More Than 70 Subpoenas and Letters Investigating Hillary Clinton Just Since the FBI's Decision on Emails in July
"Desperate Onslaught of Frivolous Attacks"
Cummings, Brady, and Clyburn Call on EAC Executive Director to Rescind Unilateral Action
Newby Failed to Weigh Potential for Voter Disenfranchisement
Cummings Issues Statement on Inaccurate Republican Leaks About Limited Immunity Agreement with Cheryl Mills
Washington, DC (Sept. 23, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to inaccurate Republican leaks regarding a limited immunity agreement for Cheryl Mills:
All Democrats on Oversight and Ways and Means Committees Warn Judiciary Committee:
Do Not Promote Baseless Accusations Against IRS Commissioner
Ranking Members Release New Letters with IRS Inspector General
Oversight Committee to Hold Hearing on EpiPen Price Increases
Washington, D.C. (Sept. 14, 2016)—On Wednesday, September 21, 2016, the House Committee on Oversight and Government Reform will hold a bipartisan hearing with officials from Mylan, which dramatically increased its prices for EpiPens.
Republican FCC Commissioners Obstructing Investigation By Withholding Documents from Oversight Committee
Issues Letter Seeking Documents Relating to Widespread Corporate Abuses
Washington, D.C. (Sept. 13, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, met with Wells Fargo President and Chief Operating Officer Tim Sloan to hear about steps the company is taking to hold employees and executives accountable for opening more than 2 million unauthorized accounts and to make whole the consumers who have suffered from these abuses.
Letter Criticizes Republican Pattern of "Accuse, Investigate, Fail, Repeat"
Washington, D.C. (Sept. 9, 2016)—Today, Rep. Elijah E.